Clindamycin is used to study bacterial infections, such as group B streptococcal disease, bacterial resistance and plasma protein binding .
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
|Alternate Names||(7S)-7-Chloro-7-deoxylincomycin hydrochloride; Cleocin|
|Application Notes||Clindamycin is used to study bacterial infections, such as group B streptococcal disease, bacterial resistance and plasma protein binding .|
|Base Catalog Number||191168|
|Beilstein Registry Number||4070786|
|Biochemical Physiological Actions||Spectrum of Activity: Gram positive cocci and taxoplasma. Especially active against anaerobic bacteria.Mode of Action: Inhibits protein synthesis in bacteria by binding the 50s ribosomal subunit.Clindamycin is a semi-synthetic, lincosamide antibiotic that is prepared from lincomycin. It inhibits bacterial protein synthesis by hydrogen bond interactions with the 23S rRNA component of the 50S ribosomal subunit thus inducing dissociation of the peptidyl-t-RNA complex. Antibacterial and antiprotozoal antibiotic.|
|Molecular Formula||C18H33ClN2O5S • HCl|
|Molecular Weight||461.439 g/mol|
|Solubility||In <a class="pubchem-internal-link CID-962" href="https://pubchem.ncbi.nlm.nih.gov/compound/water">water</a>, 30.61 mg/L at 25 deg C (est)|
|Vapor Pressure||5.28X10-17 mm Hg at 25 deg C (est)|